Home Toxicology Prehospital olanzapine for meth toxicity
Toxicology
Prehospital olanzapine for meth toxicity
Impact of prehospital olanzapine for methamphetamine intoxication on patient and system-level outcomes: a population-based retrospective cohort study
BMJ Open · Added 13 October 2026
Population-based Winnipeg cohort evaluating a 2018 policy letting paramedics give olanzapine for methamphetamine intoxication — treated patients were far more likely to be transported to ED (aOR 11.83) and seen by a doctor, and less likely to leave before being seen (aOR 0.56).
- Study type
- Cohort
- Design
- Retrospective pre-post population-based cohort (inverse probability of treatment weighting)
- Participants
- 1,041 individuals with methamphetamine-related contacts, 222 given prehospital olanzapine
- Main finding
- Olanzapine recipients more likely to be transported to ED (aOR 11.83, 95% CI 3.19–43.80) and less likely to leave ED without being seen (aOR 0.56, 95% CI 0.32–0.97)
- Caveat
- Retrospective pre-post design with confounding by indication — the sickest patients were presumably the ones treated
- Bottom line
- Hypothesis-generating
Why it matters in Australia (High relevance). Olanzapine for agitation is carried by all seven Australian ambulance services and methamphetamine presentations are a daily reality, so the system-level findings translate directly.
Learning goal
Weigh the benefits and risks of prehospital olanzapine for methamphetamine intoxication and its impact on transport decisions.
More
- Topic: Toxicology
- Daily scan: 13 October 2026
Related papers on Toxicology
-
Prehospital flumazenil: 69 doses, no seizures
A five-year Kansas review of 69 prehospital flumazenil administrations for suspected benzodiazepine overdose found clinical improvement with no seizures or adverse events recorded, even where possible contraindications existed.
-
US prehospital buprenorphine growing fast
A national cross-sectional analysis of 167 million US EMS encounters found 2,180 prehospital buprenorphine administrations between 2020 and 2023, rising from 33 to 1,574 per year, with 80% of patients improving and only 16% of 911 cases transported.
-
Ice-water immersion wins for drug hyperthermia
A systematic review of 71 studies (1,932 patients) comparing cooling methods for drug-induced (and exercise-induced) hyperthermia found ice-water and cold-water immersion fastest at ~0.16–0.17 °C/min and clearly superior to passive cooling.
-
Poisoning OHCA rising in young Japanese adults
In 1.4 million Japanese EMS-treated OHCAs, poisoning-related arrest was rare (0.27%) but its share rose in adults aged 18–29 (adjusted OR 1.027/year) while falling in older groups, with no improvement in neurological outcomes over the decade.